Which Is Better: Ozempic or Mounjaro?

Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The choice between semaglutide and tirzepatide depends on your individual metabolism, weight loss goals, and how your body responds to different hormone pathways. Both medications work through the glucagon-like peptide-1 system, but tirzepatide adds a second mechanism that may offer superior results for some patients. PlexusDx provides access to compounded versions of both, plus genetic testing to describe the pathway-level variants involved.

How Semaglutide and Tirzepatide Work Differently

Semaglutide activates only the GLP-1 receptor, a hormone pathway that slows stomach emptying, reduces hunger signals, and increases feelings of fullness. This single-pathway approach has proven effective, with clinical studies showing an average weight loss of 10-15% of body weight over 68 weeks in patients with obesity.

Tirzepatide activates both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor, creating a dual-action mechanism. This combination engages more of your body's natural appetite and metabolism regulation systems. In the SURMOUNT clinical trial program, tirzepatide demonstrated weight loss ranging from 15-21% of body weight depending on the dose, representing a meaningful difference compared to single-pathway therapy.

The dual-pathway approach in tirzepatide may offer additional benefits for blood sugar regulation and metabolic flexibility, which can be especially valuable for patients with insulin resistance or prediabetes alongside obesity.

Clinical Trial Comparisons: Semaglutide vs Tirzepatide

Head-to-head comparison data shows tirzepatide generally produces greater weight loss than semaglutide at equivalent clinical timepoints. In the SURMOUNT-4 trial, tirzepatide at its highest dose achieved approximately 21% weight loss, while semaglutide at its maximum dose achieved roughly 15% in comparable populations. However, both medications showed substantial improvements in quality of life, mobility, and cardiovascular risk markers.

Gastrointestinal side effects occur with both medications, though some patients report slightly different symptom profiles between the two. Semaglutide users commonly experience nausea in early weeks that often resolves with dose optimization, while tirzepatide users may experience similar patterns with the potential for additional GI effects due to dual-pathway activation.

Individual response varies significantly. Some patients achieve excellent results with semaglutide and experience fewer side effects, while others respond dramatically better to tirzepatide's dual mechanism. This variability is partly genetic, which is why PlexusDx offers Precision Peptide Genetic Testing to identify your specific peptide-pathway predispositions.

Cost and Access: Compounded vs Brand-Name Options

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with no insurance required and no membership fees. All compounds are manufactured in licensed 503A compounding pharmacies, maintaining pharmaceutical-grade quality while offering significant savings compared to brand-name Mounjaro, which often costs $1,000+ monthly even with insurance.

Semaglutide from PlexusDx is $189/mo month-to-month, or from $149/mo on the 6-month plan for the injection form, making it the most accessible entry point for patients new to GLP-1 therapy. Oral versions of both medications are also available at higher price points for patients who prefer tablets to injections. Both are HSA and FSA eligible, providing additional tax-advantaged savings options.

Your dose may increase over time as your body adapts, but PlexusDx pricing remains flat across the dosing range. This means you won't face escalating monthly costs as your treatment advances to optimal therapeutic levels.

Personalized Selection: Using Genetic Testing to Choose Your Compound

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with certain FTO rs9939609 variants may show enhanced response to tirzepatide's dual mechanism, while those with specific GLP1R patterns sometimes achieve excellent results with semaglutide monotherapy. The $298 genetic test adds clarity to the choice, helping you and your PlexusDx provider select the compound most likely to work for your unique metabolism.

This precision approach eliminates months of trial-and-error dosing and reduces the likelihood of switching medications after weeks of adjustment. You start with a compound matched to your genetic predispositions, significantly improving your pathway to sustainable weight loss.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide always better than semaglutide for weight loss?

Tirzepatide generally produces greater average weight loss in clinical trials, but individual response varies significantly based on genetics, metabolism, and lifestyle. Some patients achieve excellent results with semaglutide alone. PlexusDx genetic testing describes the pathway-level variants involved.

What clinical evidence supports tirzepatide's superior weight loss?

The SURMOUNT clinical trial program demonstrated tirzepatide weight loss ranging from 15-21% of body weight, compared to approximately 15% for semaglutide at equivalent timepoints. Tirzepatide's dual GLP-1 and GIP receptor activation engages additional metabolic pathways, though both medications show meaningful benefits across multiple health markers.

Does PlexusDx compounded tirzepatide work the same as brand-name Mounjaro?

PlexusDx tirzepatide is manufactured in licensed 503A compounding pharmacies using pharmaceutical-grade tirzepatide base, making it bioequivalent to the brand name. The main difference is cost: PlexusDx is $289 monthly month-to-month, or from $249/mo on the 6-month plan versus $1,000+ for brand-name Mounjaro with insurance, and pricing remains flat regardless of dose level.

What are the side effect differences between these two medications?

Both cause similar gastrointestinal side effects like nausea and reduced appetite, particularly in early weeks. Some patients report tirzepatide produces slightly different symptom patterns due to GIP receptor activation. Side effect severity often decreases after 2-4 weeks as your body adjusts, and slower dose titration can minimize initial discomfort.

How does the Precision Peptide Genetic Test help choose between them?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic Vs Mounjaro 2
• Mounjaro Vs Ozempic 2
• Ozempic Vs Mounjaro
• Mounjaro Vs Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.